Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Promazine 25mg/5ml oral solution
0402010S0AAADAD
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | 8,857 |
|
Promazine 25mg tablets
0402010S0AAAEAE
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | 7,285 |
|
Promazine 50mg tablets
0402010S0AAAFAF
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | 3,778 |
|
Promazine 50mg/5ml oral solution
0402010S0AAAIAI
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | 3,046 |
|
Prazine 25mg tablets
0402010S0BDAAAE
|
Prazine | Promazine hydrochloride | Central Nervous System | No data available |
|
Promazine 10mg/5ml oral liquid
0402010S0AAAQAQ
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | No data available |
|
Promazine 12.5mg/5ml oral liquid
0402010S0AAAMAM
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | No data available |
|
Promazine 25mg/5ml oral suspension
0402010S0AAALAL
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | No data available |
|
Promazine 50mg/5ml oral suspension
0402010S0AAANAN
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | No data available |
|
Promazine 6.25mg/5ml oral liquid
0402010S0AAARAR
|
Promazine hydrochloride | Promazine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.